Table 1.

Trans-disease meta-analysis results for loci meeting criteria

Marker ID	Chr	Position (hg19)	Alleles (risk/non-risk)b	TDMA Direction	Meta-analysis P-values			Meta-analysis Odds ratios			Risk allele frequenciesa		Nearby genes
					Psoriasis	CAD	TDMA	Psoriasis	CAD	TDMA	Psoriasis	CAD
rs6430076	2	145797185	G/A	Opposing	8.2 × 10−5	1.8 × 10−6	1.6 × 10−8	0.92	1.05	1.07	0.35	0.32	TEX41, ZEB2
rs1990760	2	163124051	T/C	Shared	5.7 × 10−15	5.3 × 10−5	1.3 × 10−18	1.16	1.04	1.10	0.61	0.56	IFIH1
rs76151170	12	56659320	C/T	Shared	9.8 × 10−16	6.0 × 10−5	2.8 × 10−19	1.38	1.09	1.23	0.94	0.94	IL23A. COQ10A
rs12979495	19	10964632	G/A	Shared	1.3 × 10−5	4.7 × 10−10	2.5 × 10−11	1.10	1.07	1.08	0.74	0.75	DNM2, ILF3

Chr chromosome, OR odds ratio, p p-value, CAD coronary artery disease.

^aAllele frequencies are provided for each entire meta-analysis (cases and controls), rather than specifically for each disease.

^bRisk allele corresponds to TDMA. Gene names are italicized.